semaglutide solution for injection Compound Compounded Semaglutide for Women |

It is labeled for use as an adjunct to diet and exercise for chronic weight management in adults classified as obese (body mass index [BMI] of 30 kg per m2 or greater) or overweight (BMI of 27 kg per m2 or greater) in the presence of one weight-related comorbidity

list price as of April 2026 (Novo Nordisk published pricing)

da Silva Junior ALS, Nascimento MM, Santos HM, Lbo IP, de Oliveira RA, de Jesus RM

The patient was a 44-year-old male with severe morbid obesity, heart failure, oxygen-dependent obesity hypoventilation syndrome, uncontrolled hypertension, anemia, and depression

GLP-1 (Glucagon-Like Peptide-1) agonists work by: Increasing insulin secretion Delaying gastric emptying Reducing appetite via central mechanisms The result

Sensitivity analyses showed that the probability of using GLP-1RAs versus insulin being cost-effective for preventing one case of all-cause mortality or hospitalized hypoglycemia ranged from 60 to 100%